🇺🇸 FDA
Patent

US 11447453

Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof

granted A61KA61K31/4196A61K31/426

Quick answer

US patent 11447453 (Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof) held by SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
Grant date
Tue Sep 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/4196, A61K31/426, A61K31/427, A61K31/433